This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cutler, D., McClellan, M. & Newhouse, J. The Costs and Benefits of Intensive Treatment for Cardiovascular Disease (The American Enterprise Institute for Public Policy Research/Brookings Institution, Washington, D.C., December 1997).
Frank, R.G., Berndt, E. & Busch, S.H. Price Indexes for the Treatment of Depression (The American Enterprise Institute for Public Policy Research/Brookings Institution, Washington, D.C., December 1997).
Fagan, S.C. et al. Neurology 50, 883–889 (1998).
Legg, R.F. et al. J. Occupational Environmental Med. 39, 652–657 (1997).
Rights and permissions
About this article
Cite this article
Reply to Democracy unleashed—unpacking the tooth fairy in drug industry R&D. Nat Biotechnol 24, 1326–1327 (2006). https://doi.org/10.1038/nbt1106-1326
Issue Date:
DOI: https://doi.org/10.1038/nbt1106-1326
This article is cited by
-
Privatizing biomedical research—a 'third way'
Nature Biotechnology (2008)